Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early tirofiban after intravenous thrombolysis for acute ischemic stroke
ChiCTR2400086525Phase 4Not yet recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in ischemic stroke (2 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoints: 90-day mRS score, 90-day mortality rate and 1 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400086525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086525.